P Husa

Summary

Affiliation: University Hospital
Country: Czech Republic

Publications

  1. ncbi [Triple combination treatment of chronic hepatitis C]
    P Husa
    Klinika infekcních chorob Lékarské fakulty MU a FN Brno
    Vnitr Lek 58:588-90. 2012
  2. ncbi [Prevalence and risk factors of hepatitis C in Roma people in Brno]
    Petr Husa
    Clinic of Infectious Diseases of the University Hospital Brno, Masaryk University Brno, Czech Republic
    Klin Mikrobiol Infekc Lek 17:201-7. 2011
  3. ncbi [Diagnosis and management of chronic hepatitis B]
    P Husa
    Klinika infekcních chorob Lékarské fakulty MU a FN Brno, pracoviste Bohunice, prednosta
    Klin Mikrobiol Infekc Lek 14:36-44. 2008
  4. doi Efficacy and safety of peginterferon α-2a (40 kD) plus ribavirin among patients with chronic hepatitis C and earlier treatment failure to interferon and ribavirin: an open-label study in central and Eastern Europe
    Petr Husa
    Department of Infectious Diseases, Faculty Hospital and Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic
    Eur J Gastroenterol Hepatol 23:375-81. 2011
  5. ncbi [Liver abscesses - one of possible causes of fever of unknown origin]
    P Husa
    Klinika Infekcních Chorob Lékarské Fakulty Masarykovy Univerzity a Fulkultní Nemocnice Brno
    Klin Mikrobiol Infekc Lek 15:58-64. 2009
  6. ncbi [Diagnosis and treatment of chronic hepatitis B. Recommendations of the Czech Hepatology Society of the J. E. Purkinje Medical Society and the Society of Infectious Medicine of the J.E. Purkinje Medical Society]
    P Husa
    Klinika infekcních chorob Lékarské fakulty MU a FN Brno, pracoviste Bohunice
    Vnitr Lek 53:1221-30. 2007
  7. ncbi Treatment of chronic hepatitis C patients with combination of alpha-interferon and ribavirin, consensus and pegylated interferons
    P Husa
    Department of Infectious Diseases, Teaching Hospital, Jihlavska 20, CZ 639 00 Brno, Czech Republic
    Bratisl Lek Listy 102:248-52. 2001
  8. ncbi Autoantibodies to asialoglycoprotein receptor in chronic hepatitis C patients
    P Husa
    Department of Infectious Diseases, University Hospital, Brno, Czech Republic
    Acta Virol 45:7-11. 2001
  9. ncbi Efficacy and safety of chronic hepatitis C treatment in hemophilic patients
    P Husa
    Department of Infectious Diseases, University Hospital Brno, Czech Republic
    Hepatogastroenterology 52:1541-4. 2005
  10. ncbi Hepatitis D
    P Husa
    Department of Infectious Diseases, University Hospital Brno, Jihlavska 20, 625 00 Brno, Czech Republic
    Acta Virol 49:219-25. 2005

Collaborators

Detail Information

Publications21

  1. ncbi [Triple combination treatment of chronic hepatitis C]
    P Husa
    Klinika infekcních chorob Lékarské fakulty MU a FN Brno
    Vnitr Lek 58:588-90. 2012
    ....
  2. ncbi [Prevalence and risk factors of hepatitis C in Roma people in Brno]
    Petr Husa
    Clinic of Infectious Diseases of the University Hospital Brno, Masaryk University Brno, Czech Republic
    Klin Mikrobiol Infekc Lek 17:201-7. 2011
    ..Assessment of hepatitis C prevalence in a representative sample of Roma people in the town of Brno and determination of the main risk factors of this disease...
  3. ncbi [Diagnosis and management of chronic hepatitis B]
    P Husa
    Klinika infekcních chorob Lékarské fakulty MU a FN Brno, pracoviste Bohunice, prednosta
    Klin Mikrobiol Infekc Lek 14:36-44. 2008
  4. doi Efficacy and safety of peginterferon α-2a (40 kD) plus ribavirin among patients with chronic hepatitis C and earlier treatment failure to interferon and ribavirin: an open-label study in central and Eastern Europe
    Petr Husa
    Department of Infectious Diseases, Faculty Hospital and Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic
    Eur J Gastroenterol Hepatol 23:375-81. 2011
    ..To assess the safety and efficacy of 48 weeks of re-treatment with peginterferon α-2a (40 kD) plus ribavirin in previously treated hepatitis C virus (HCV) genotype 1 patients...
  5. ncbi [Liver abscesses - one of possible causes of fever of unknown origin]
    P Husa
    Klinika Infekcních Chorob Lékarské Fakulty Masarykovy Univerzity a Fulkultní Nemocnice Brno
    Klin Mikrobiol Infekc Lek 15:58-64. 2009
    ..Three amebic liver abscesses were diagnosed in 27-years old man of Indian origin. The treatment was based on drainage of abscesses under CT control a long-term metronidazol treatment...
  6. ncbi [Diagnosis and treatment of chronic hepatitis B. Recommendations of the Czech Hepatology Society of the J. E. Purkinje Medical Society and the Society of Infectious Medicine of the J.E. Purkinje Medical Society]
    P Husa
    Klinika infekcních chorob Lékarské fakulty MU a FN Brno, pracoviste Bohunice
    Vnitr Lek 53:1221-30. 2007
    ..LAM and LdT treatments are often accompanied by the appearance of mutant strains of HBV, that are resistant to lamivudine or LdT and therefore they are not preferred...
  7. ncbi Treatment of chronic hepatitis C patients with combination of alpha-interferon and ribavirin, consensus and pegylated interferons
    P Husa
    Department of Infectious Diseases, Teaching Hospital, Jihlavska 20, CZ 639 00 Brno, Czech Republic
    Bratisl Lek Listy 102:248-52. 2001
    ..We can expect the development more potent antiviral drugs or immune modulators for patients, which are primary resistant to alpha-interferon. (Tab. 3, Ref. 31)..
  8. ncbi Autoantibodies to asialoglycoprotein receptor in chronic hepatitis C patients
    P Husa
    Department of Infectious Diseases, University Hospital, Brno, Czech Republic
    Acta Virol 45:7-11. 2001
    ....
  9. ncbi Efficacy and safety of chronic hepatitis C treatment in hemophilic patients
    P Husa
    Department of Infectious Diseases, University Hospital Brno, Czech Republic
    Hepatogastroenterology 52:1541-4. 2005
    ..Chronic hepatitis C infection is very common among hemophiliacs in the developed World...
  10. ncbi Hepatitis D
    P Husa
    Department of Infectious Diseases, University Hospital Brno, Jihlavska 20, 625 00 Brno, Czech Republic
    Acta Virol 49:219-25. 2005
    ..The results of antiviral therapy of hepatitis D patients are not satisfactory. Alpha-interferon (alpha-IFN) in high doses (9-10 MU three times a week for 12 months) is usually recommended...
  11. ncbi Efficacy of alpha-interferon therapy of chronic hepatitis patients infected with wild type hepatitis B virus and HBEAG-minus mutant
    P Husa
    Department of Infectious Diseases, University Hospital Brno, Czech Republic
    Acta Virol 45:293-7. 2001
    ..Nevertheless, 4 of 7 patients of group B were negative for HBV DNA 12 months after the treatment and HBV DNA was eliminated during the treatment in all patients of group C; however, 3 patients relapsed after the treatment...
  12. ncbi Treatment of chronic hepatitis C in hemophilic patients
    P Husa
    Department of Infectious Diseases, University Hospital Brno, Jihlavska 20, 625 00 Brno, Czech Republic
    Acta Virol 48:35-8. 2004
    ..We conclude that the efficacy and tolerability of the treatment of chronic hepatitis C in hemophiliacs did not differ from that of chronic hepatitis C in other patients...
  13. ncbi [Atypital localisation of pyoderma gangraenosum in patient with ulcerative colitis]
    L Husova
    Interní gastroenterologická klinika Lékarské fakulty MU a FN Brno
    Vnitr Lek 51:1400-5. 2005
    ..However endoscopic examination of the intestine confirmed the finding of chronically active ulcerative colitis with ulcerations and bridging polyps. Patient was indicated to total colectomy, but he refused it...
  14. ncbi [Blood lipid changes at long-term antiretroviral treatment]
    S Snopkova
    Klinika infekcních chorob Lékarské fakulty MU a FN Brno
    Vnitr Lek 57:463-71. 2011
    ..We followed changes during the therapy and evaluated their aterogennic nature...
  15. ncbi [The influence of some factors on presence of varices and variceal bleeding in liver cirrhosis patients]
    L Husova
    Interní gastroenterologická klinika Lékarské fakulty MU a FN Brno
    Vnitr Lek 57:61-71. 2011
    ..A statistical evaluation was performed of a range of haematological and biochemical parameters, spleen size and a thrombocyte, leucocyte and erythrocyte count to spleen size ratio...
  16. ncbi [HIV lipodystrophy]
    S Snopkova
    Klinika infekcních chorob Lékarské fakulty MU a FN Brno
    Vnitr Lek 56:1217-22. 2010
    ..The question, whether metabolic and morphological changes related to HIV and cART carry a similar atherogenic potential as in the general population, remains open for future...
  17. ncbi [Ascites in Mulibrey syndrome]
    L Husova
    Interní hepatogastroenterologická klinika Lékarské fakulty MU a FN Brno
    Vnitr Lek 55:604-7. 2009
    ..Subjective complaints improved when adequate diuretic therapy was introduced and ascites was managed with conservative therapy without the need for further paracentesis...
  18. ncbi Bacterial infection and acute bleeding from upper gastrointestinal tract in patients with liver cirrhosis
    L Husova
    Department of Gastroenterology, University Hospital Brno, Czech Republic
    Hepatogastroenterology 52:1488-90. 2005
    ..It is believed that bacterial infection may be the immediate cause of the bleeding and the latest meta-analyses show that bacterial infection is an independent predictive factor of the failure to stop bleeding...
  19. ncbi [Multiple brain abscesses of odontogenic origin caused by Fusobacterium nucleatum]
    L Stefániková
    Klinika infekcních chorob Lékarské fakulty Masarykovy univerzity a Fakultní nemocnice Brno
    Klin Mikrobiol Infekc Lek 14:149-53. 2008
    ..Four and eight months after the onset of the disease, MRI scans revealed only persistent residual changes in the brain parenchyma; the patient was asymptomatic, with no neurological signs and back at work...
  20. ncbi [Warning about risk of invasive infections in splenectomized patients. Experiences from University Hospital Brno, Czech Republic, in 2011]
    P Polak
    Klinika infekcních chorob Lékarské fakulty MU a FN Brno, pracoviste Bohunice
    Vnitr Lek 58:665-7. 2012
    ..The authors present case reports of three splenectomized patients who were hospitalized for invasive pneumococcal infection in the University Hospital Brno, Czech Republic, in 2011...
  21. ncbi Treatment of chronic hepatitis B in 2002
    P Husa
    Department of Infectious Diseases, University Hospital, Masaryk University, Brno, Czech Republic
    Bratisl Lek Listy 104:59-63. 2003
    ..These approaches are including antisense oligonucleotides, ribozymes, inhibitors blocking virus entry into hepatocytes, and decoy virus or dominant negative mutants...